Fusion Antibodies plc (AIM:FAB)
London
· Delayed Price · Currency is GBP · Price in GBX 14.80
+1.30 (9.62%)
Apr 28, 2026, 4:24 PM GMT
Fusion Antibodies Market Cap
Fusion Antibodies has a market cap or net worth of 16.88 million as of April 28, 2026. Its market cap has increased by 127.39% in one year.
Market Cap
16.88M
Enterprise Value
17.01M
Revenue
1.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
14.80
Market Cap Chart
Since December 18, 2017, Fusion Antibodies's market cap has decreased from 27.28M to 16.88M, a decrease of -38.14%. That is a compound annual growth rate of -5.58%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| IXICO | 15.26M |
| Aptamer Group | 20.73M |
| Genflow Biosciences | 13.39M |
| Arecor Therapeutics | 24.92M |
| SkinBioTherapeutics | 25.27M |
| ImmuPharma | 28.08M |
| Sareum Holdings | 28.99M |
| Oxford BioDynamics | 9.44M |